EIP
WST icon

Epoch Investment Partners’s West Pharmaceutical WST Stock Holding History

Epoch Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202M Buy
562,557
+17,507
+3% +$5.35M 1.15% 16
2026
Q1 		$137M Buy
545,050
+39,745
+8% +$9.89M 0.83% 26
2025
Q4 		$139M Sell
505,305
-20,594
-4% -$5.63M 0.79% 37
2025
Q3 		$138M Buy
525,899
+164,634
+46% +$40M 0.76% 40
2025
Q2 		$79M Buy
361,265
+31,472
+10% +$6.73M 0.41% 95
2025
Q1 		$73.8M Buy
329,793
+57,268
+21% +$15.8M 0.38% 99
2024
Q4 		$89.3M Buy
272,525
+9,981
+4% +$3.14M 0.43% 80
2024
Q3 		$78.8M Sell
262,544
-7,131
-3% -$2.18M 0.35% 113
2024
Q2 		$88.8M Buy
269,675
+9,156
+4% +$3.24M 0.41% 85
2024
Q1 		$103M Buy
260,519
+37,051
+17% +$13.7M 0.46% 74
2023
Q4 		$78.7M Buy
223,468
+99,076
+80% +$35.1M 0.36% 92
2023
Q3 		$46.7M Sell
124,392
-7,180
-5% -$2.78M 0.3% 120
2023
Q2 		$50.3M Sell
131,572
-2,842
-2% -$1.02M 0.29% 121
2023
Q1 		$46.6M Sell
134,414
-1,783
-1% -$521K 0.28% 124
2022
Q4 		$32.1M Buy
136,197
+63,185
+87% +$15M 0.19% 165
2022
Q3 		$18M Buy
73,012
+674
+0.9% +$205K 0.12% 201
2022
Q2 		$21.9M Buy
72,338
+855
+1% +$278K 0.13% 200
2022
Q1 		$29.4M Buy
71,483
+18,690
+35% +$7.32M 0.14% 181
2021
Q4 		$24.8M Sell
52,793
-376
-0.7% -$162K 0.13% 189
2021
Q3 		$22.6M Buy
53,169
+1,560
+3% +$658K 0.13% 193
2021
Q2 		$18.5M Buy
51,609
+873
+2% +$288K 0.1% 202
2021
Q1 		$14.3M Sell
50,736
-94
-0.2% -$26.9K 0.07% 219
2020
Q4 		$14.4M Buy
50,830
+1,816
+4% +$510K 0.07% 203
2020
Q3 		$13.5M Buy
+49,014
New +$13M 0.07% 195

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Epoch Investment Partners's WST Position: Q2 2026 in Review

Epoch Investment Partners increased its West Pharmaceutical (WST) stake by 3.2% in Q2 2026, buying an estimated $5.35M and bringing the position to 562,557 shares worth $202M. The position accounts for 1.15% of the portfolio, ranked #16.

Epoch Investment Partners first reported a position in WST in Q3 2020 and has held it in 24 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Epoch Investment Partners held 562,557 shares of West Pharmaceutical worth $202M as of Q2 2026.
  • Epoch Investment Partners bought 17,507 West Pharmaceutical shares in Q2 2026, an estimated $5.35M.
  • West Pharmaceutical made up 1.15% of Epoch Investment Partners's portfolio in Q2 2026, its #16 holding.
  • Epoch Investment Partners first reported a position in West Pharmaceutical in Q3 2020 and has held it in 24 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Epoch Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.